Inlexzo is a new treatment for a type of bladder cancer in adults that hasn’t spread to the muscles and doesn’t respond to Bacillus Calmette-Guérin (BCG) therapy. It’s approved for treating non-muscle ...
A new drug-releasing system, TAR-200, eliminated tumors in 82% of patients in a phase 2 clinical trial for individuals with high-risk non-muscle-invasive bladder cancer whose cancer had previously ...
Of the approximately 82,000 people diagnosed with bladder cancer in the U.S. each year [1], many find their quality of life completely upended. Between demanding symptoms, side effects of treatment, ...
A research team is shedding new light on Bacillus Calmette-Guerin (BCG), a decades-old bladder cancer treatment, which is also given as vaccine against tuberculosis. The findings could help improve ...
“You have cancer.” Few words carry more weight. For people diagnosed with non–muscle invasive bladder cancer (NMIBC), advances in the field can be encouraging; yet, even amid innovation and ongoing ...
Hydrogels, which are soft materials formed by crosslinking polymers, could have a variety of medical applications. In research published in Advanced Science, investigators developed an injectable ...
Treatment for interstitial cystitis, or bladder pain syndrome (IC/BPS), includes lifestyle changes such as avoiding certain foods and managing stress. A doctor may also suggest medications, bladder ...
Historic surgery, the result of years of research at Keck Medicine of USC and UCLA Health, opens the door for improved treatment of non-functioning bladders “This surgery is a historic moment in ...
Hydrogels, which are soft materials formed by crosslinking polymers, could have a variety of medical applications. In research published in Advanced Science, investigators developed an injectable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback